Brazil's Actions and Reactions in the Fight Against COVID-19 from January to March 2020.

The outbreak of the novel coronavirus SARS-CoV-2 and the disease it causes, COVID-19, which emerged in 2019, was identified by the World Health Organization as a public health emergency of international concern. Brazil actively responded to contain the virus. This case study aims to examine Brazil's response to COVID-19 by investigating the country's actions and reflecting upon the outcomes throughout January and March 2020. The data collection strategy included gathering data from the country's intergovernmental organization's official website, epidemiological bulletins, and news reports, guided by intersectoral and interdisciplinary themes. Although the highest incidence rates were in the most rich and populated region in Brazil, it was the poorest region that had the highest case fatality rate. Nevertheless, Brazil took several non-pharmaceutical measures to control and mitigate the spread of the virus. However, the strategy seems to have failed to consider regional and social inequalities. The actions of the health minister were undermined by a conflicting discourse between the minister and the president. The outbreak of COVID-19 added an extra burden on the country's healthcare system and the existing economic crises; exacerbated the inherent social, political, and economic challenges; and exposed the country's contradictions.

A method to assess seasonality of urinary tract infections based on medication sales and google trends.

BACKGROUND: Despite the fact that urinary tract infection (UTI) is a very frequent disease, little is known about its seasonality in the community. METHODS AND FINDINGS: To estimate seasonality of UTI using multiple time series constructed with available proxies of UTI. Eight time series based on two databases were used: sales of urinary antibacterial medications reported by a panel of pharmacy stores in France between 2000 and 2012, and search trends on the Google search engine for UTI-related terms between 2004 and 2012 in France, Germany, Italy, the USA, China, Australia and Brazil. Differences between summers and winters were statistically assessed with the Mann-Whitney test. We evaluated seasonality by applying the Harmonics Product Spectrum on Fast Fourier Transform. Seven time series out of eight displayed a significant increase in medication sales or web searches in the summer compared to the winter, ranging from 8% to 20%. The eight time series displayed a periodicity of one year. Annual increases were seen in the summer for UTI drug sales in France and Google searches in France, the USA, Germany, Italy, and China. Increases occurred in the austral summer for Google searches in Brazil and Australia. CONCLUSIONS: An annual seasonality of UTIs was evidenced in seven different countries, with peaks during the summer.